Jiang L, Li H, Bao W, Zhang A, et al. Qingre Runzao oral liquid and its key compound ophiopogonin D inhibit CXCL9 and block CXCL9/CXCR3 axis to ameliorate asthma by suppressing RAS/ERK pathway. Respir Res 2026 May 21. doi: 10.1186/s12931-026-03723.
PMID: 42169113